NCT05076682 2025-12-03
Renaissance
Fudan University
Phase 2 Recruiting
Clinical Trials
4 trialsNCT04009941 2020-10-28
Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer
Peking University
Phase 4 Completed
NCT02944604 2019-01-18
The Efficacy and Safety of PEG-rhG-CSF（Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy
Peking University
Phase 4 Completed
NCT02761460 2017-06-01
The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia
Sun Yat-sen University
Phase 3 Unknown